Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning BOSTON & LJUBLJANA, Slovenia--(BUSINESS WIRE)--#ISO27001--Genialis, a computational precision medicine company ...